Cypress acquires worldwide license for Staccato nicotine technology from Alexza Pharma

More info…
Cypress Bioscience, Inc. announced that it has licensed Alexza Pharmaceutical’s Staccato nicotine technology – a novel electronic multidose delivery technology designed to help people stop smoking.

drug rehab

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • YahooMyWeb
  • Google Bookmarks
  • Yahoo! Buzz
  • TwitThis
  • Live
  • LinkedIn
  • Pownce
  • MySpace

Leave a Comment

Security Code:

Previous post:

Next post: